Table 3 Complications of the studies included in the meta-analysis
Complications | ES, %(95 CI) | I2 |
|---|---|---|
instability | 1.5%(0–5.1%) | 44.39% |
Pain | 0.6%(0%,2.6%) | 0 |
Infection | 1.7%(0.1%,4.2%) | 0 |
hematoma | 0.2%(0%,1.7%) | 0 |
Myocutaneous nerve disorders | 0.1%(0%,1.7%) | 0 |
Arthritis | 3.9%(0%,13.6%) | 83.44% |
Graft fragmentation | 0.2%(0%,1.7%) | 0 |
Total | 9.4%(1.0%, 23.6%) | 86.57% |